Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients

Serum anti-HLA-I IgG are present in non-alloimmunized males, cancer patients, and transplant recipients. Anti-HLA-I antibodies are also present in intravenous immunoglobulin (IVIg), prepared from the plasma of thousands of healthy donors. However, the HLA-Ia reactivity of IVIg diminishes markedly af...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravindranath, Mepur H., Ravindranath, Narendranath M., El Hilali, Fatiha, Selvan, Senthamil R., Filippone, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944535/
https://www.ncbi.nlm.nih.gov/pubmed/35323192
http://dx.doi.org/10.3390/antib11010018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944535/
https://www.ncbi.nlm.nih.gov/pubmed/35323192
http://dx.doi.org/10.3390/antib11010018

Ejemplares similares